Open-Label, Randomized, Single-Dose, 2-Way Crossover Pivotal Bioequivalence Study Comparing Alprazolam Immediate Release (IR) Tablets (Administered Orally) And Alprazolam Sublingual (SL) Tablets (Administered Sublingually).
Phase of Trial: Phase I
Latest Information Update: 09 Dec 2009
At a glance
- Drugs Alprazolam; Alprazolam
- Indications Generalised anxiety disorder
- Focus Pharmacokinetics
- 14 Nov 2009 Actual patient number (23) added as reported by ClinicalTrials.gov.
- 03 Nov 2009 Actual end date (Oct 2009) added as reported by ClinicalTrials.gov.
- 03 Nov 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.